Carrick NewsroomPress Releases

Discovery Named to Inc. 500 List for the Fifth Straight Year

Discovery Health Logo.jpg

Latest recognition places Discovery in the Hall of Fame among elite group of fastest-growing private companies

Itasca, IL – Discovery Health Partners today announced that for the fifth year in a row, the company has been named to Inc. Magazine’s annual Inc. 5000 list, the most prestigious ranking of the nation’s fastest-growing private companies. Discovery has earned a spot on the list since 2014, when it debuted at #100. This year, Discovery’s three-year growth rate of 115 percent landed the company at #3364 on the list. Discovery’s fifth-straight appearance on the list also puts them in the 5-Time Inc. 5000 Honoree Hall of Fame. According to Inc. Magazine, only one in ten companies who earn a spot on the Inc. 5000 list repeat that achievement five times.

“It’s an honor to be ranked among the fastest-growing companies in America for the fifth consecutive year,” said Discovery CEO Jason Brown. “To sustain our growth trajectory for this long is truly a testament to our entire team at Discovery and the work we’re doing to continue our tradition of creating profound value for our clients and delivering innovative solutions to meet their changing needs.”

The Inc. 5000 list provides a glimpse into America’s most dynamic economic segment—its independent small businesses. To qualify for the list, companies must have been founded and generated revenue by March 31, 2014, and be based in the U.S., privately held, for profit, and independent as of December 31, 2017.

See this year’s full Inc. 5000 list here.

About Discovery Health Partners

Discovery Health Partners’ mission is to deliver unique, actionable analytic insights and technology-powered solutions to help healthcare payers improve payment integrity, increase revenue optimization, and maximize efficiencies with government programs. Serving more than 60 health plans across the U.S., including five of the 10 largest U.S. health plans, Discovery has been recognized consistently for its growth—earning a spot on the Inc. 5000 list five years in a row and the Crain’s Fast 50 three times. For more information on Discovery Health Partners, go to

About Carrick Capital Partners
Who We Are
A firm of enterprise software and technology enabled services investors and operating executives with substantial experience founding, scaling, and optimizing market leading businesses.
Our Approach
We work with management to identify and improve critical areas of their business - focusing on the priorities that align with our experiences and that will deliver the highest strategic impact in both the short-term and long-run.
Why We Are Different
We have a concentrated number of companies in our portfolio so that we can build substantial relationships with each management team and ensure our firm's commitment to each company's goals.
Latest News
Accolade Logo.jpg
Global Technology Company Apptio Modernizes and Simplifies their Employee Healthcare and Benefits Experience by Bringing Accolade Connect to its Employees and their Family Members
February 20, 2019
Saama Logo
Campbell, CA (February 19, 2019) - Saama Technologies, Inc., a leading data analytics company, today unveiled three new, machine learning-based capabilities that extend the existing functionality of its award-winning Life Science Analytics Cloud (LSAC). Saama announced the addition of these state-of-the-art programs infused with artificial intelligence (AI) -- Virtual Assistant/AI, Operational and Financial Risk Mitigation, and Drug Efficacy and Patient Safety Analytics -- during the 10th Annual Summit for Clinical Ops Executives (SCOPE) in Orlando.
February 19, 2019
Axiom Logo.jpg
New York, NY (February 19, 2019) - Axiom Global Inc. today announced it has confidentially submitted a draft registration statement on Form S-1 with the Securities and Exchange Commission (the “SEC”) relating to the proposed initial public offering of its common stock. The number of shares to be offered and the price range for the proposed offering have not yet been determined. The proposed offering is subject to, among other things, completion of the SEC review process and market conditions.
February 19, 2019